The fast-moving pace of social media, and the powerful amplifying effect that it can have on perceptions about a brand, means that even for the bravest of businesses it can be a daunting space. And for pharma companies the added regulatory boundaries and compliance constraints do not always go hand-in-hand with the norms of social media. But that is no reason to stay away from the game.
While there is evidence of ‘social anxiety’ across the global pharma industry, many organisations are getting involved in the online conversation. Ogilvy CommonHealth has conducted an analysis of these brands to understand the landscape and identify the trends and best practices that are driving pharma companies’ success in social media.
In the presentation below, we share the results of the study, answering the questions:
- What is the landscape and how has it changed?
- Who are the top performers and why?
- What are the best practices?